140 related articles for article (PubMed ID: 23351306)
1. A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study.
Bazl R; Ganjali MR; Saboury AA; Foroumadi A; Nourozi P; Amanlou M
Daru; 2012 Oct; 20(1):64. PubMed ID: 23351306
[TBL] [Abstract][Full Text] [Related]
2. Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.
Kandalkar SR; Ramaiah PA; Joshi M; Wavhal A; Waman Y; Raje AA; Tambe A; Ansari S; De S; Palle VP; Mookhtiar KA; Deshpande AM; Barawkar DA
Bioorg Med Chem; 2017 Oct; 25(20):5799-5819. PubMed ID: 28951094
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
Porter DJ; Abushanab E
Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
Singhal D; Anderson BD
J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
8. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase.
Caiolfa VR; Gill D; Parola AH
FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
Lambe CU; Nelson DJ
Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and
Arun KG; Sharanya CS; Abhithaj J; Sadasivan C
J Recept Signal Transduct Res; 2020 Feb; 40(1):77-88. PubMed ID: 31971048
[TBL] [Abstract][Full Text] [Related]
12. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase.
Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P
Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
Ullman B; Cohen A; Martin DW
Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
[TBL] [Abstract][Full Text] [Related]
14. A Label-Free Fluorescent Assay for the Rapid and Sensitive Detection of Adenosine Deaminase Activity and Inhibition.
Tang X; Wu K; Zhao H; Chen M; Ma C
Sensors (Basel); 2018 Jul; 18(8):. PubMed ID: 30060448
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
[TBL] [Abstract][Full Text] [Related]
16. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
18. Immobilized capillary adenosine deaminase microreactor for inhibitor screening in natural extracts by capillary electrophoresis.
Ji X; Ye F; Lin P; Zhao S
Talanta; 2010 Sep; 82(4):1170-4. PubMed ID: 20801314
[TBL] [Abstract][Full Text] [Related]
19. The adenosine deaminases of Plasmodium vivax and Plasmodium falciparum exhibit surprising differences in ligand specificity.
Ivanov A; Matsumura I
J Mol Graph Model; 2012 May; 35():43-8. PubMed ID: 22481078
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.
Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M
J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
